National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 32340-32341 [E8-12644]
Download as PDF
<![CDATA[
32340
Federal Register / Vol. 73, No. 110 / Friday, June 6, 2008 / Notices
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 30, 2008.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–12642 Filed 6–5–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
PWALKER on PROD1PC71 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors for Basic
Sciences National Cancer Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: July 14, 2008.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31, Conference Room 6,
Bethesda, MD 20892,
Time: 6 p.m. to 10 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: DoubleTree Hotel, 8120 Wisconsin
Avenue, Bethesda, Md 20814.
Contact Person: Florence E. Farber, PhD,
Executive Secretary, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6116 Executive Boulevard, Room
2205, Bethesda, MD 20892, 301–496–7628,
ff6p@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
VerDate Aug<31>2005
16:09 Jun 05, 2008
Jkt 214001
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsc/bs/bs.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 30, 2008.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–12645 Filed 6–5–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Ancillary Studies.
Date: July 7, 2008.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Atul Sahai, PhD, Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
759, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–2242,
sahaia@niddk.nih.gov.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Hormonal Control.
Date: July 14, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michael W. Edwards, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8886,
edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Ancillary Studies to
Ongoing Clinical Research.
Date: July 16, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michael W. Edwards, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8886,
edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Drug-Induced Liver
Disease.
Date: July 18, 2008.
Time: 8:45 a.m. to 2:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Maria E. Davila-Bloom,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 758, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davilabloomm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Steroid Hormone
Receptors.
Date: July 18, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michael W. Edwards, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8886,
edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, R13 Conference
Grant Application.
Date: July 19, 2008.
E:\FR\FM\06JNN1.SGM
06JNN1
Federal Register / Vol. 73, No. 110 / Friday, June 6, 2008 / Notices
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: D. G. Patel, PhD, Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
756, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 30, 2008.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–12644 Filed 6–5–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Post-Contract Award Information
Office of the Chief Procurement
Officer, Acquisition Policy and
Legislation Office, DHS.
ACTION: 60-Day Notice and request for
comments: Extension without change of
a currently approved collection, 1600–
0003.
PWALKER on PROD1PC71 with NOTICES
AGENCY:
SUMMARY: The Department of Homeland
Security, Office of the Chief
Procurement Officer, Acquisition Policy
and Legislation Office, will submit the
following information collection request
(ICR) to the Office of Management and
Budget (OMB) for review and clearance
in accordance with the Paperwork
Reduction Act of 1995 (Pub. L. 104–13
(as amended), 44 U.S.C. Chapter 35).
The Office of the Chief Procurement
Officer is soliciting comments related to
its request for extension of an existing
information collection authority for
information collected from contractors
during the post-contract award phase of
public contract administration under
Homeland Security Acquisition
Regulation (HSAR).
DATES: Comments are encouraged and
will be accepted until August 5, 2008.
This process is conducted in accordance
with 5 CFR 1320.1
ADDRESSES: Comments and questions
about this Information Collection
Request should be forwarded to the
Acquisition Policy and Legislation
Office, Attn: Patricia Corrigan for the
Department of Homeland Security,
VerDate Aug<31>2005
16:09 Jun 05, 2008
Jkt 214001
Office of the Chief Procurement Officer,
Room 3114, Washington, DC 20528.
FOR FURTHER INFORMATION CONTACT:
Patricia Corrigan, 202–447–5430 (this is
not a toll free number).
SUPPLEMENTARY INFORMATION: The
Department of Homeland Security
(DHS), Office of the Chief Procurement
Officer requests renewal of an existing
OMB Control Number for information
requested from contractors as part of
post-contract award administration by
DHS acquisition officials. The
information requested is specific to each
transaction and is required in order for
DHS acquisition officials to properly
assess contractor technical and
management progress in meeting
contractual requirements and otherwise
performing in the Government’s best
interest. This notice provides a request
for renewal of OMB Control Number
1600–0003 previously granted in August
2005.
The Office of Management and Budget
is particularly interested in comments
regarding:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
Analysis:
Agency: Department of Homeland
Security, Office of the Chief
Procurement Officer, Acquisition Policy
and Legislation Office.
Title: Post-Contract Award
Information.
OMB Number: 1600–0003.
Frequency: Once.
Affected Public: Individuals and
Businesses.
Number of Respondents: 4,061.
Estimated Time per Respondent: 14
hours.
Total Burden Hours: 170,562 annual
burden hours.
Total Burden Cost (capital/startup):
$0.00.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
32341
Total Burden Cost (operating/
maintaining): $0.00.
Richard Mangogna,
Chief Information Officer.
[FR Doc. E8–12669 Filed 6–5–08; 8:45 am]
BILLING CODE 4410–10–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2008–0054]
Review and Revision of the National
Infrastructure Protection Plan
National Protection and
Programs Directorate, DHS.
ACTION: Notice and request for
comments.
AGENCY:
SUMMARY: This notice informs the public
that the Department of Homeland
Security (DHS) is currently reviewing
the National Infrastructure Protection
Plan (NIPP) and, as part of a
comprehensive national review process,
solicits public comment on issues or
language in the NIPP that need to be
updated in this triennial review cycle.
DATES: Written comments must be
submitted on or before July 7, 2008.
ADDRESSES: Comments must be
identified by docket number DHS–
2008–0054 and may be submitted by
one of the following methods:
• Federal Rulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• E-mail: Nipp@dhs.gov. Include the
docket number in the subject line of the
message.
• Facsimile: 703–235–3057.
• Mail: Larry L. May, NPPD/IP/POD/
NIPP Program Management Office; Mail
Stop 8530, Department of Homeland
Security, 245 Murray Lane, SW.,
Washington, DC 20528–8530.
FOR FURTHER INFORMATION CONTACT:
Larry L. May, Deputy Director, NIPP
Program Management Office (PMO)
Partnership and Outreach Division,
Office of Infrastructure Protection,
National Protection and Programs
Directorate, Department of Homeland
Security, Washington, DC 20528, 703–
235–3648 or NIPP@dhs.gov.
SUPPLEMENTARY INFORMATION:
I. Public Participation
DHS invites interested persons to
contribute suggestions and comments
for the revision of the National
Infrastructure Protection Plan (NIPP) by
submitting written data, views, or
arguments. Comments that will provide
the most assistance to DHS in revising
the NIPP will explain the reason for any
E:\FR\FM\06JNN1.SGM
06JNN1
]]>Agencies
[Federal Register Volume 73, Number 110 (Friday, June 6, 2008)]
[Notices]
[Pages 32340-32341]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-12644]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Ancillary Studies.
Date: July 7, 2008.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Atul Sahai, PhD, Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 759,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-2242,
sahaia@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Hormonal Control.
Date: July 14, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Michael W. Edwards, PhD, Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8886, edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Ancillary Studies to
Ongoing Clinical Research.
Date: July 16, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Michael W. Edwards, PhD, Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8886, edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Drug-Induced Liver
Disease.
Date: July 18, 2008.
Time: 8:45 a.m. to 2:45 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Maria E. Davila-Bloom, PhD, Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 758, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-7637, davila-bloomm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Steroid Hormone
Receptors.
Date: July 18, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Michael W. Edwards, PhD, Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8886, edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, R13 Conference Grant
Application.
Date: July 19, 2008.
[[Page 32341]]
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: D. G. Patel, PhD, Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 756,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: May 30, 2008.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-12644 Filed 6-5-08; 8:45 am]
BILLING CODE 4140-01-P
